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D1 dopamine receptors are primary mediators of
dopaminergic signaling in the CNS. These receptors
internalize rapidly following agonist-induced activa-
tion, but the functional significance of this process
is unknown.We investigatedD1 receptor endocytosis
and signaling in HEK293 cells and cultured striatal
neurons using real-time fluorescence imaging and
cAMP biosensor technology. Agonist-induced acti-
vation of D1 receptors promoted endocytosis of
receptorswitha timecourseoverlapping that of acute
cAMP accumulation. Inhibiting receptor endocytosis
blunted acute D1 receptor-mediated signaling in both
dissociated cells and striatal slice preparations.
Although endocytic inhibition markedly attenuated
acute cAMP accumulation, inhibiting the subsequent
recycling of receptors had no effect. Further, D1
receptors localized in close proximity to endomem-
brane-associated trimeric G protein and adenylyl
cyclase immediately after endocytosis. Together,
these results suggest a previously unanticipated
role of endocytosis, and the early endocytic pathway,
in supporting rapiddopaminergic neurotransmission.
INTRODUCTION
Dopamine (DA) is a major catecholamine neurotransmitter that
controls a diverse range of physiological processes (Missale
et al., 1998; Sibley, 1999). Disturbances of dopaminergic
signaling have been implicated in many pathological conditions
including Parkinson’s disease, schizophrenia, attention-deficit/
hyperactivity disorder and addiction. Not surprisingly, dopami-
nergic signaling in the central nervous system (CNS) is highly
regulated and subject to precise temporal control. All of the
known cellular actions of DA are mediated by G protein coupled
receptors (GPCRs). D1 DA receptors are highly expressed within
the brain. Their pharmacological properties suggest they
mediate signaling in response to transient bursts of high extra-
cellular DA concentration characteristic of phasic release (Heien
and Wightman, 2006; Richfield et al., 1989) Upon binding DA, D1278 Neuron 71, 278–290, July 28, 2011 ª2011 Elsevier Inc.receptors activate adenylyl cyclase (AC) through coupling to
specific heterotrimeric G-proteins (Gs or Golf) and produce
a dynamic increase in the concentration of cytoplasmic 30-50-
cyclic adenosine monophosphate (cAMP) that transduces
many D1 receptor-mediated signaling effects (Greengard, 2001;
Neve et al., 2004).
In order for neurons to respond to physiologically relevant fluc-
tuations in extracellular DA, D1 receptors must be able to reliably
transduce and support changes in intracellular cAMP concentra-
tion over appropriate time intervals. After agonist-induced
activation, D1 receptors are subject to a linked series of regula-
tory events that culminate in endocytic removal of receptors
from the plasma membrane in numerous cell lines, as well as
the intact brain (Ariano et al., 1997; Bloch et al., 2003; Dumartin
et al., 1998; Martin-Negrier et al., 2000, 2006; Mason et al., 2002;
Ng et al., 1994; Tiberi et al., 1996; Vickery and von Zastrow,
1999). Previous studies of GPCRs indicate that endocytic
removal of receptors from the cell surface can attenuate cellular
signaling, and/or contribute to later functional recovery of cellular
responsiveness by returning surface receptors by recycling. For
some GPCRs, endocytosis promotes receptor dephosphoryla-
tion, thus promoting biochemical recovery (or resensitization)
of receptors from the desensitized state after a refractory period
(Lefkowitz, 1998; Pippig et al., 1995). However, none of these
processes is thought to affect the signaling response to acute
agonist activation. Further, D1 dopamine receptors can undergo
dephosphorylation in the absence of endocytosis (Gardner et al.,
2001). Thus the functional significance of D1 receptor endocy-
tosis remains unknown.
Previous studies examining the relationship between signaling
and endocytosis of D1 receptors have been carried out on a time
scale of tens of minutes to hours, but fluctuations of extracellular
DA in the CNS occur much faster- typically on the order of
seconds to less than one minute (Heien and Wightman, 2006).
Thus we considered the possibility that the functional signifi-
cance of D1 receptor endocytosis involves more rapid events,
andmay have remained elusive due to the limited temporal reso-
lution of previous work. In the present study, we applied recent
advances in live imaging and fluorescent biosensor technologies
to analyze both D1 receptor trafficking and receptor-mediated
cAMP accumulation with greatly improved temporal resolution,
beginning to approach that of physiological dopamine fluctua-
tions. Our results show that D1 receptors endocytose more
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Figure 1. Rapid Agonist-Stimulated D1 Receptor Endocytosis and Real-Time Examination of Receptor-Mediated Regulation of Cellular
cAMP
(A) Agonist-induced effects on surface receptor number as analyzed by fluorescence flow cytometry. Surface fluorescence of labeled FD1Rs measured at time
0 was defined as 100%. Data = mean fluorescence values ± SEM, n = 3, 10,000 cells/condition, each time point in duplicate.
(B) Representative images of SpH-D1R surface fluorescence visualized by TIRF microscopy prior to (left, inset) and 120 s after DA addition (right, inset).
(C)Maximum intensity trace of representative SpH-D1R endocytic cluster versus time. Trace represents area outlined in blue in (B),measurements taken every 4 s.
(D) Normalized integrated surface fluorescence of SpH-D1R measured every 3 s in the absence of agonist (Bleaching Control, n = 5 cells) or in response to DA
(10 mM DA, n = 20 cells). Integrated fluorescence value at time 0 was defined as 100%. Data = mean ± SEM.
(E) Representative pseudo-color image of Epac1-cAMPs FRET prior to (left) or 60 s. after 10 mM DA addition (right). Lookup table is scaled linearly to YFP/CFP
emission ratio.
(F) Change in normalized Epac1-cAMPs FRET signal in response to stimulation over a range of DA concentrations. Data =mean ± SEMnormalized FRET emission
ratio at each time point, n = 8–16 cells per dose. Scale bars represent 5 mm.
See also Figure S1.
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D1 Receptor Endocytosis and Signalingrapidly than previously recognized, and reveal an unanticipated
role of regulated endocytosis of D1 receptors in promoting the
acute response. Our findings thus identify a specific conse-
quence of the endocytic machinery on D1 receptor-mediated
signaling, and its function in a physiologically relevant model of
dopaminergic neurotransmission.
RESULTS
Real-Time Analysis of D1 Receptor Endocytosis
by Live Cell Imaging
Flow cytometric analysis of surface accessibility of FLAG
epitope-tagged D1 DA receptors (FD1R) in HEK293 cells verifiedrobust internalization in response to DA. Internalization was
dose-dependent and rapid, approaching the steady state
value with an estimated t1/2 of 3.9 min (Figure 1A). For greater
temporal resolution, we employed live imaging by total internal
reflection fluorescence (TIRF) microscopy and the pH-sensitive
GFP variant superecliptic pHluorin (SpH, or SEP) fused to the
N-terminal extracellular region of the D1 receptor (SpH-D1R).
SpH is highly fluorescent at neutral pH, facilitating detection
when in contact with the extracellular media. This fluorescence
is rapidly quenched in the acidic environment of the endocytic
pathway (Miesenbo¨ck et al., 1998; Sankaranarayanan et al.,
2000). We used these properties to observe individual endocytic
events in SpH-D1R expressing HEK293 cells. In the absence ofNeuron 71, 278–290, July 28, 2011 ª2011 Elsevier Inc. 279
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D1 Receptor Endocytosis and SignalingDA, SpH-D1R fluorescence was visible on the plasma mem-
brane (Figure 1B, left). Bath application of DA caused rapid clus-
tering of SpH-D1Rs into puncta that subsequently endocytosed
(Figure 1B, right; see Movie S1 available online). Strikingly, an
initial wave of SpH-D1R clustering and endocytosis occurred
as soon as 30 s after agonist addition (Movie S1). Analysis of indi-
vidual puncta by fluorescence intensity tracing verified their
disappearance within 30 s to 1 min after formation (Figure 1C).
These properties are consistent with previous data indicating
that D1 receptors endocytose primarily via clathrin-coated pits
in HEK293 cells (Vickery and von Zastrow, 1999), and with
descriptions of clathrin-mediated endocytosis of signaling
receptors imaged by TIRF microscopy (Puthenveedu and von
Zastrow, 2006; Yudowski et al., 2006). Rapid endocytosis was
further verified by the rate of DA-dependent reduction in inte-
grated SpH-D1R surface fluorescence intensity (Figure 1D).
Real-Time Measurement of cAMP Dynamics
Using a FRET-Based Biosensor
Given that significant endocytosis of D1 receptors occurred
within 1 min of DA addition, we examined D1 receptor-medi-
ated signaling over a similar time scale. We employed the
FRET-based cAMP biosensor, Epac1-cAMPs, to measure DA
stimulated cAMP production in real time, in individual cells,
without phosphodiesterase inhibitors (Nikolaev et al., 2004).
Cells expressing FD1R and Epac1-cAMPs showed a robust
decrease in the normalized FRET emission ratio after DA addi-
tion, indicating elevated cytoplasmic cAMP concentration (Fig-
ure 1E). DA application produced both a rapid decrease of
YFP emission and a corresponding increase in CFP emission,
verifying that the observed changes were indeed due to
decreased FRET (Figure S1A). Incubation of FD1R/Epac1-
cAMPs expressing cells with a range of DA concentrations re-
vealed a significant and dose-dependent increase in cyto-
plasmic cAMP concentration beginning within 20 s (Figure 1F).
We did not observe significant changes in Epac1-cAMPs FRET
in the absence of agonist (Figure S1B). Dual-channel fluores-
cence imaging indicated that coexpression of Epac1-cAMPs
did not prevent agonist-induced endocytosis of D1 receptors
(Figure S1C).
Endocytosis Promotes Acute D1 Receptor-Mediated
Signaling
In light of the temporal overlap between agonist-induced D1
receptor trafficking and signaling, we asked if there is a causal
relationship between these processes. We employed a number
of experimental manipulations to inhibit receptor endocytosis,
and examined effects on acute cAMP accumulation using the
Epac1-cAMPs FRET biosensor. Hypertonic sucrose (HS) inhibits
clathrin-mediated endocytosis of a number of membrane
proteins, including D1 receptors, by disrupting the normal cla-
thrin lattice structure (Gardner et al., 2001; Heuser and Ander-
son, 1989; Vickery and von Zastrow, 1999). HS indeed inhibited
FD1R endocytosis, as verified by fluorescence microscopy (Fig-
ure S2A) and quantified by fluorescence flow cytometry (Fig-
ure S2B). Further, this manipulation partially attenuated acute
D1 receptor-mediated cAMP accumulation measured using the
Epac1-cAMPs biosensor (Figure S2C).280 Neuron 71, 278–290, July 28, 2011 ª2011 Elsevier Inc.Dynasore inhibits clathrin/dynamin-dependent endocytosis
by interfering with the GTPase activity of dynamin (Kirchhausen
et al., 2008). Dynasore visually reduced regulated endocytosis of
FD1Rs (Figure 2A) and caused a near complete blockade of this
process as quantified by fluorescence flow cytometry (Fig-
ure 2B). DA-stimulated cAMP accumulation was significantly in-
hibited by dynasore (Figure 2C). Dynasore caused a small shift in
baseline fluorescence signal due to its low level of intrinsic fluo-
rescence (Figure S2D) but this was easily corrected by subtrac-
tion (see Supplemental Experimental Procedures). Importantly,
dynasore did not affect the cAMP accumulation elicited by
receptor-independent activation of adenylyl cyclase with forsko-
lin (Figure S2E). Thus chemical inhibition of endocytosis
produces significant inhibition of cellular cAMP accumulation
mediated specifically by D1 receptor activation.
We next used an independent genetic approach, based on
depleting clathrin heavy chain with a validated small interfering
RNA (siRNA). Knockdown was confirmed biochemically by
immunoblot (Figure 2D). Clathrin knockdown blocked FD1R
internalization measured by flow cytometry (Figure 2E), and
significantly inhibited acute DA-stimulated cAMP accumulation
(Figure 2F).
Given that clathrin-coated pits mediate endocytosis of a wide
range of membrane cargo, it is possible that the inhibited
signaling produced by all of our endocytic manipulations could
reflect an indirect consequence not specific to endocytosis of
the D1 receptor itself. To address this, we used a receptor-
specificmutation to inhibit endocytosis of D1 receptors. Amiddle
portion of the D1 receptor cytoplasmic tail (residues 360–382) is
not essential for ligand binding or receptor function but contains
several residues subject to agonist-induced phosphorylation
that affect endocytic trafficking of D1 receptors (Jackson et al.,
2002; Kim et al., 2004; Lamey et al., 2002; Mason et al., 2002).
We constructed a mutant version of the D1 receptor with these
residues deleted and verified significant inhibition of DA-induced
endocytosis compared to the wild-type receptors expressed at
the same level (Figure 2G). The endocytosis-defective mutant
D1 receptor produced a significantly blunted cellular cAMP
accumulation response relative to its wild-type counterpart (Fig-
ure 2H). Nevertheless, dose-response analysis revealed
unchanged potency (indistinguishable EC50; Figure S2F). This
verifies that deletion of residues 360–382 did not simply prevent
activated receptors from coupling to the transduction pathway,
as would be indicated by a rightward shift. Interestingly, the
earliest phase of D1 receptor-mediated cAMP accumulation
did not seem to be affected by dynasore pretreatment or expres-
sion of the endocytosis-deficient mutant. The mean effects of
each of the endocytic manipulations at 20 s and 120 s after
agonist treatment are summarized in Figure 2I.
Rapid Endocytic Trafficking of D1 Receptors in Cultured
Striatal Neurons
We next asked whether a causal relationship between D1
receptor endocytosis and acute cAMP signaling also exists in
neurons. D1 receptors are expressed on a substantial fraction
of GABAergic medium spiny neurons (MSNs), which represent
the major cell type present within the striatum (Kreitzer, 2009).
Because MSNs also express other DA receptor subtypes
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Figure 2. Endocytic Inhibitors Reduce Acute, D1 Receptor-Mediated, cAMP Accumulation in HEK293 Cells
(A) Subcellular distribution of surface-labeled FD1Rs in response to 10 mM DA in the absence (left) or presence (right) of 80 mM dynasore.
(B) Agonist-induced effects on surface receptor number in the presence of 80 mM dynasore (white) or 0.2% DMSO (black) as analyzed by fluorescence flow
cytometry. Fluorescence measured at time 0 was defined as 100%. Data = mean surface fluorescence ± SEM, n = 3, 10,000 cells/condition, each time point
in triplicate.
(C) Change in normalized Epac1-cAMPs FRET in response to 10 mM DA in the presence of 80 mM dynasore (open squares) or 0.2% DMSO (vehicle; filled black
circles). Data = mean ± SEM normalized FRET ratio at each time point, n = 21–22 cells per group.
(D) Representative (n = 3) immunoblot analysis of siRNA mediated knockdown of clathrin in FD1R-expressing cells with GAPDH loading control.
(E) Agonist-induced effects on surface receptor number for cells transfectedwith clathrin siRNA (crosshatch) or nonsilencing control siRNA (black) as analyzed by
fluorescence flow cytometry. Fluorescence measured at time 0 was defined as 100%. Data = mean surface fluorescence ± SEM, n = 3, 10,000 cells/condition,
each time point in triplicate.
(F) Change in normalized Epac1-cAMPs FRET in response to 10 mMDA in cells transfectedwith clathrin siRNA (open triangles) or nonsilencing control siRNA (filled
circles). Data = mean ± SEM normalized FRET ratio at each time point, n = 14–15 cells per group.
(G) Agonist-induced effects on surface receptor number for cells expressing wild-type (black) or 360-382 deletion mutant D1 receptors (gray), as analyzed by
fluorescence flow cytometry. Fluorescencemeasured at t = 0was defined as 100%.Data =mean surface fluorescence ± SEM, n = 3, 10,000 cells/condition, each
time point in triplicate.
(H) Change in normalized Epac1-cAMPs FRET in response to 10 mM DA in cells expressing wild-type (closed circles) or 360-382 deletion mutant D1Rs (gray
squares). Data = mean ± SEM normalized FRET emission ratio at each time point, n = 30-31 cells per group.
(I) Mean difference in cAMP response between each endocytic manipulation and corresponding control at 20 s (black) or 120 s (white) after DA addition. Data =
difference in mean normalized FRET ratio ± variance at each time point. Scale bar represents 5 mm. (*p < 0.05, **p < 0.01 by 2-tailed unpaired t test).
See also Figure S2.
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D1 Receptor Endocytosis and Signaling(notably D2 receptors that are oppositely coupled to AC), we
used the D1-selective full agonist SKF81297 rather than dopa-
mine in our neuronal studies. To quantitatively examine receptor
internalization, FD1Rs were expressed in cultured striatal
neurons and plasma membrane receptors labeled with mono-
clonal antibody conjugated to red Alexafluor (Figure 3A). Cells
were incubated in the absence of agonist (Figure 3A, top) or in
the presence of the D1 receptor-specific agonist SKF81297 (Fig-ure 3A, bottom), and fixed under nonpermeabilizing conditions.
Labeled receptors still present in the plasma membrane
were subsequently labeled with a green Alexafluor-conjugated
secondary antibody. Accordingly red fluorescence represents
the overall pool (internal and surface) of D1 receptors initially
on the plasma membrane, and green fluorescence represents
the fraction of D1 receptors that did not internalize. The ratio
of these integrated fluorescence values was used to assessNeuron 71, 278–290, July 28, 2011 ª2011 Elsevier Inc. 281
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Figure 3. Rapid, Agonist-Induced Traffick-
ing of D1 Receptors in Striatal Neurons
(A) Representative, epifluorescence images of
FD1R-expressing striatal neurons after 10 min
incubation with (bottom) or without (top) of 1 mM
SKF 81297. The total pool of FD1Rs initially
present at the cell surface were labeled with
Alexa594-conjugated primary antibody (red). After
agonist treatment, neurons were fixed under
nonpermeabilizing conditions and incubated with
Alexa488-conjugated secondary antibody (green)
to label receptors that remained at the cell surface
or recycled during the incubation period.
(B) Quantification of FD1R internalization by
change in normalized (surface/total) fluorescence
ratio as described in (A). The average surface to
total (green/red) fluorescence ratio measured in
nontreated cells was defined as 1. Data = mean
fluorescence ratios ± SEM, n = 3, 31–36 cells per
condition.
(C) Representative images of SpH-D1R surface
fluorescence in striatal neurons as visualized by
TIRF microscopy prior to (left, inset), and 120 s
after SKF 81297 addition (right, inset). Arrows
indicate clusters of SpH-D1R fluorescence that
formed after SKF addition and disappeared
shortly thereafter, arrowhead indicates a cluster of
that formed after SKF addition and persisted
throughout imaging.
(D) Kymograph of SpH-D1R fluorescence for en-
docytic events indicated by arrows in (C). Kymo-
graph depicts surface fluorescence intensity
(maximum intensity determination) as a function of
time. Arrow indicates bath application of 1 mMSKF
81297.
(E) Average surface fluorescence of SpH-D1R
expressing striatal neurons measured every 3 s
in the absence of (bleaching control) or in response
to 1 mM SKF 81297. Initial fluorescence values
normalized to 100%, data = background-cor-
rected, mean surface fluorescence ± SEM, n =
5-9 cells/condition. Scale bars represent 5 mm.
See also Figure S3.
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D1 Receptor Endocytosis and Signalinginternalization across multiple neurons and experiments, estab-
lishing that D1 receptors internalize rapidly and robustly after
activation in medium spiny neurons (Figure 3B).
To examine receptor dynamics at the cell surface with
greater temporal resolution, we imaged SpH-D1Rs by TIRF
microscopy. SpH-D1R fluorescence was observed on the
plasma membrane of both the cell body and dendrites (Fig-
ure 3C, left). Pronounced clustering of receptors occurred
very rapidly after agonist addition (Figure 3C, right and Movie
S2), characteristic of receptor concentration in clathrin-coated
pits using this method (Yu et al., 2010; Yudowski et al.,
2006). The vast majority disappeared within 1 min of their
formation, indicating the occurrence of rapid endocytic scission
consistent with clathrin-dependent endocytosis. Figure 3D
shows a representative kymograph of these events. Integrated
SpH-D1R fluorescence intensity measurements established the
overall kinetics of regulated D1 receptor endocytosis (Figure 3E,
black circles). SpH-D1R surface fluorescence remained steady
in the absence of agonist (Figure 3E, gray circles), confirming282 Neuron 71, 278–290, July 28, 2011 ª2011 Elsevier Inc.that D1 receptor endocytosis is agonist-dependent and that
photobleaching was negligible. We also verified FD1R localiza-
tion to clathrin-associated puncta within 2 min after agonist
addition (Figure S3A), and to early endosomes marked by
EEA1 within 5 min after agonist addition (Figure S3B) by dual
labeling.
Endocytosis Promotes Acute D1 Receptor-Mediated
Signaling in Striatal Neurons
We adapted the FRET-based biosensor technology used to
study HEK293 cells to assess D1 receptor-mediated signaling
in striatal neurons. Due to the typically lower expression of
Epac1-cAMPs in neurons compared to HEK293 cells, we
used TIRF microscopy to achieve greater signal-to-noise ratio
and facilitate FRET determination with high quantitative preci-
sion despite lower cytoplasmic biosensor concentration. The
evanescent field produced by TIRF illumination field extends
100 nm beyond the thickness of the plasma membrane
and includes a significant volume of peripheral cytoplasm
0 sec. 60 sec.
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Figure 4. Endocytic Inhibition Reduces
Acute D1 Receptor-Mediated cAMP Accu-
mulation in Striatal Neurons
(A) Pseudo-color representation of Epac1-cAMP
FRET in FD1R / Epac1-cAMPs expressing striatal
neuron prior to (left) or 60 s after addition of 1mM
SKF 81297 (right). Lookup table is scaled linearly to
YFP/CFP emission ratio.
(B) Change in normalized Epac1-cAMPs FRET
signal in response to stimulation with 1 mM SKF
81297. Data = mean normalized FRET emission
ratio ± SEM at each time point, n = 7.
(C) Change in normalized Epac1-cAMPs FRET in
response to 1 mM SKF 81297 in the presence of
80 mM dynasore (open squares) or 0.2% DMSO
(Vehicle; filled circles). Data represent mean
normalized FRET emission ratio ± SEM at each
time point, n = 13–18 cells per group.
(D) Change in normalized Epac1-cAMPs FRET in
response to 1 mM SKF 81297 in cells expressing
wild-type (filled circles) or 360-382 deletion mutant
D1Rs (open diamonds). Data = mean normalized
FRET emission ratio ± SEM at each time point,
n = 12–15 cells per group. (*p < 0.05, **p < 0.01 by
2-tailed unpaired t test) Scale bar represents 5 mm.
See also Figure S4.
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D1 Receptor Endocytosis and Signaling(Steyer and Almers, 2001). Acute D1 receptor activation
induced by bath application of SKF81297 caused a
pronounced decrease in the normalized (YFP/CFP) emission
ratio of Epac1-cAMPs throughout the peripheral cytoplasm
(Figure 4A), indicating increased cAMP concentration occur-
ring rapidly after agonist application (Figure 4B). Dynasore
caused a pronounced inhibition of D1 receptor endocytosis in
MSNs (Figure S4) and, consistent with results from HEK293
cells, inhibited acute agonist-induced cAMP accumulation
(Figure 4C). Genetic inhibition of D1 receptor endocytosis,
by 360–382 deletion, also blunted the rapid cAMP response
(Figure 4D). These data provide two independent lines of
evidence indicating that the endocytic machinery promotes
acute D1 receptor-mediated cAMP accumulation in physiolog-
ically relevant neurons.
Endocytosis Promotes D1 Receptor-Mediated
Regulation of Action Potential Firing in Dorsolateral
Striatum
Agonist-stimulation of D1 receptors in dorsolateral striatum
increases neuronal excitability via PKA-dependent enhance-
ment of L-type calcium currents (Abdallah et al., 2009; Herna´n-
dez-Lo´pez et al., 1997; Surmeier et al., 1995). Further, endoge-
nous D1 receptors undergo agonist-induced internalization in
this brain region (Dumartin et al., 1998; Muriel et al., 2002). To
examine whether endocytosis affects integrated D1 receptor-
mediated signaling, we performed whole-cell patch-clamp elec-
trophysiology in intact brain slices containing the lateral dorsal
striatum. Neurons were brought to a resting membrane potential
of 90 mV by passage of DC current via the patch amplifier
and subsequently exposed to a series of 300msec current
pulses to depolarize neurons and generate APs. In control slices
preexposed to vehicle (0.2% DMSO), perfusion of SKF 81297
significantly enhanced AP generation as expected (Figure 5A,top). Interestingly, preexposure of slices to dynasore strongly in-
hibited this response (Figure 5A, bottom). This inhibitory effect of
dynasore on D1 receptor-mediated AP firing was robust across
experiments. Importantly, dynasore did not affect basal firing
(Figure 5B). The time course of increased AP firing observed in
vehicle-perfused slices is consistent with that of D1 receptor-
mediated signaling in this preparation and, after accounting for
perfusion lag time, closely paralleled that of acute cAMP
signaling measured in dissociated MSNs. We further verified
that dynasore did not alter the basic firing properties of MSNs
in this preparation (Figure S5) using a previously established
method (Hopf et al., 2010).
D1 Receptors Recycle Rapidly after Endocytosis, but
Recycling Is Not Required for the Acute cAMPResponse
We next investigated the mechanism by which endocytosis
promotes acute D1 receptor-mediated signaling. One possibility
is that endocytosis-dependent augmentation of cAMP accumu-
lation might require subsequent receptor recycling. This would
be predicted if endocytosis mediates a function in D1 receptor
signaling akin to resensitization of other GPCRs. We imaged
SpH-D1R insertion events with high temporal resolution using
TIRF microscopy and rapid dequenching of fluorescence upon
exposure to the neutral extracellular milieu. Vesicular insertion
events delivering SpH-tagged receptors appear as ‘‘puffs’’ of
transiently increased surface fluorescence intensity, detectable
by rapid (10 Hz) serial imaging (Yudowski et al., 2006). Such
insertions were observed immediately after DA washout (Fig-
ure 6A and Movie S3), even after prolonged exposure of cells
to the protein synthesis inhibitor cycloheximide (data not shown).
This indicates that D1 receptors can indeed undergo rapid
surface delivery. Insertion events were also observed in the
continued presence of agonist, but this required distinguishing
insertion events (Figure 6B) from the dimmer and longer-lastingNeuron 71, 278–290, July 28, 2011 ª2011 Elsevier Inc. 283
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Figure 5. Dynasore Prevents D1 Receptor-Mediated Enhancement
of Action Potential Firing in Lateral Dorsal Striatal Neurons in Brain
Slice
(A) Example traces showing increased firing with the D1 receptor agonist
SKF81297 (10 mM) after preexposure to vehicle (0.2% DMSO), but not 80 mM
dynasore. Slices were incubated as indicated (bar in B) with either vehicle
(0.2%DMSO, top pair of traces) or 80 mMdynasore (bottom pair of traces) prior
to delivery of SKF81297.
(B) Grouped data showing significant increase in firing with SKF81297 after
preexposure to vehicle (34.7 ± 12.8%, n = 5) but not dynasore (2.78 ± 4.9%,
n = 5). Bars indicate the time course of drug perfusions relative to changes in
AP firing. The percent change in number of action potentials (APs) generated
relative to baseline was determined at the current step at baseline with 4 APs
or 5 APs. If no current steps at baseline had 4 APs, the baseline number of
APs was determined by averaging each min for the 4 min before addition of
DMSO or dynasore (*p < 0.05 by 2-tailed unpaired t test).
See also Figure S5.
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D1 Receptor Endocytosis and Signalingreceptor clusters representing clathrin-coated pits (Yu et al.,
2010; Yudowski et al., 2006, 2007, 2009). Integrated fluores-
cence intensity measurements (Figure 6C) and a conventional
flow cytometric assay (Figure 6D) further verified recovery of
the surface pool of receptors within several minutes after agonist
washout.
To specifically examine recycling of the internalized receptor
pool, we analyzed surface recovery of FD1R initially labeled in
the plasma membrane of MSNs using a previously described
method (Tanowitz and von Zastrow, 2003). Figure 6E depicts
the experimental schematic. Representative images of the
conditions used to quantify D1 receptor recycling are shown in
Figure 6F. Recycling determinations averaged across multiple
neurons and experiments are shown in Figure 6G. The majority
(89.4 ± 1.8%) of internalized FD1Rs return to the neuronal
plasma membrane within 5 min after agonist washout. Together284 Neuron 71, 278–290, July 28, 2011 ª2011 Elsevier Inc.these results indicate that D1 receptors can indeed recycle very
rapidly after endocytosis.
We next searched for inhibitors of D1 receptor recycling to
examine whether, similar to endocytosis, recycling also plays
a causal role in promoting the acute D1 receptor-mediated
cAMP response. As D1 receptors return to the plasma
membrane via similar membrane pathway as transferrin recep-
tors (Vickery and von Zastrow, 1999), we investigated the effect
of a validated siRNA targeting Eps15 homology domain contain-
ing protein 3 (EHD3). EHD3 localizes to recycling membrane
structures (Galperin et al., 2002) and is required for efficient
delivery of internalized transferrin receptors to the endocytic
recycling compartment (Naslavsky et al., 2006). Knockdown of
EHD3 was verified by immunoblot (Figure 7A). EHD3 siRNA
significantly inhibited surface recovery of tagged FD1 receptors
5 min after agonist washout (Figure 7B) but did not affect acute
D1 receptor-mediated cAMP accumulation (Figure 7C).
Bafilomycin A1 is a specific inhibitor of the vacuolar
H+-ATPase that inhibits recycling of a number of signaling recep-
tors (Johnson et al., 1993; Presley et al., 1997). Pretreatment of
FD1R-expressing HEK293 cells with 500 nM bafilomycin A1
significantly inhibited surface receptor recovery compared to
cells pretreated with vehicle (Figure 7D). Nevertheless, bafilomy-
cin A1 also did not produce any detectable effect on acute D1
receptor-mediated cAMP accumulation in HEK293 cells (Fig-
ure 7E) or striatal neurons (Figure 7F). These results indicate
that the ability of D1 receptor endocytosis to augment the acute
cAMP signal does not require subsequent receptor recycling to
the plasma membrane. Instead, the results suggest that D1
receptors contribute to the acute signaling response upon entry
to, or in transit through, an early endocytic intermediate.
Endocytosis Drives D1 Receptors into Close Proximity
to Both Trimeric G Protein and Adenylyl Cyclase
To assess whether it is possible for D1 receptors to promote
acute cAMP accumulation from an endocytic intermediate, we
investigated the physical organization of internalized D1 recep-
tors relative to the relevant downstream cAMP transduction
machinery. D1 receptors stimulate agonist-dependent cAMP
production in striatal neurons by coupling to Golf, a trimeric
G protein closely related to Gs, whose liberated a-subunit
stimulates adenylyl cyclase V (ACV) (Neve et al., 2004). ACV is
an integral membrane protein, whereas Gs/olf a-subunits are
membrane-tethered by palmitoylation and associate noncova-
lently with membrane-embedded bg subunits. Gs/olf a-subunits
dissociate from bg and turn over their palmitoyl tether in
response to receptor-mediated activation, allowing them to
transiently redistribute to the cytoplasm (Marrari et al., 2007).
Thus, for signaling to occur from activated receptors entering
the endocytic pathway, both ACV and Gs/olf would need to exist
in close proximity to D1 receptors.
We examined the distribution of D1 dopamine receptors rela-
tive to ACV, using dual label immunocytochemical staining of
striatal neurons followed by laser-scanning confocal fluores-
cence microscopy. Prior to stimulation, the majority of surface-
labeled FD1R immunoreactivity was concentrated at the cell
periphery, whereas endogenous ACVwas detected both periph-
erally and associated with internal structures (Figure 8A, top).
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Figure 6. D1 Receptors Rapidly Recycle after Endocytosis
(A) Experimental schematic and representative images of SpH-D1R surface insertion events visualized by TIRF microscopy. Images acquired at 10 Hz after DA
washout.
(B) Maximum intensity trace of a representative SpH-D1R insertion event (red circle in A) versus time.
(C) Integrated surface fluorescence of plasma membrane SpH-D1R before and after DA addition and washout, as detected by TIRF imaging. Arrow indicates
application of 10 mM DA and gap indicates period of agonist washout. Data = mean integrated fluorescence values for each cell at a given time point ± SEM,
normalized to t = 0, n = 10.
(D) Agonist-induced reduction and recovery of surface FD1R immunoreactivity determined by fluorescence flow cytometry. Surface FD1R immunoreactivity was
determined in cells not exposed to agonist (NT), after 5 min incubation with 10 mM DA (50DA), or 5 min DA followed by agonist washout and incubation in fresh
media for 5 or 10 min (50wash, 100wash). Data = mean surface FD1R fluorescence ± SEM, normalized to the NT condition (defined as 100%) n = 3, 10,000 cells/
condition, each condition in duplicate.
(E) Experimental schematic to quantify recycling of internalized FD1Rs in striatal neurons by dual labeling and fluorescence ratio imaging.
(F) Representative epifluorescence images obtained using the dual labeling procedure described in (E).
(G) Quantification of FD1 receptor recycling across multiple neurons by fluorescence ratio imaging (see Experimental Procedures). Bars represent mean
percentage of internalized receptors that recycle 0 (+SKF;Strip), 5, 10, or 30 min after agonist washout ± SEM, 100% recycling = green to red fluorescence ratio
measured in unstimulated neurons, 0% recycling = green to red fluorescence ratio in neurons treated with SKF for 5 min., stripped and immediately fixed. n = 3,
21–27 cells per group. Scale bars represent 5 mm.
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(A) Representative (n = 3) immunoblot analysis of
siRNA mediated knockdown of EHD3 in FD1R-
expressing HEK293 cells with GAPDH loading
control.
(B) Recovery of surface FD1Rs measured by
fluorescence flow cytometry. Recovery of surface
FD1R fluorescence after 5 min DA incubation
and 5 or 10 min after agonist washout was
measured in cells transfected with siRNA targeting
EHD3 (gray) or nonsilencing control siRNA (black).
%Recovery = [(Surface fluorescence after DA
washout  average surface fluorescence after
5 min DA incubation)/(average initial surface fluo-
rescence  average surface fluorescence after
5 min DA incubation)] 3 100. Data = mean %
Recovery ± SEM, n = 3, 10,000 cells/well, each
time point in triplicate.
(C) Change in normalized Epac1-cAMPs FRET in response to 10 mMDA in cells transfected with siRNA against EHD3 (gray squares) or nonsilencing control siRNA
(filled circles). Data = mean normalized FRET emission ratio at each time point ± SEM, n = 20–28 cells per group.
(D) Recovery of surface FD1Rs in the presence of 500 nM Bafilomycin (white bars) or vehicle (black bars) as measured by fluorescence flow cytometry. Data =
mean %Recovery ± SEM, n = 3, 10,000 cells/well, each time point in triplicate.
(E) Change in normalized Epac1-cAMPs FRET in response to 10 mMDA in cells pretreated with Bafilomycin (open squares) or vehicle control (filled circles). Data =
mean normalized FRET emission ratio at each time point ± SEM, n = 29–30 cells per group.
(F) Change in normalized Epac1-cAMPs FRET in response to 1 mM SKF81927 in FD1 expressing striatal neurons pretreated with bafilomycin (open squares) or
vehicle control (filled circles). Data =mean normalized FRET emission ratio at each time point ± SEM, n = 11–14 neurons per group. (*p < 0.05, **p < 0.01, 2-tailed
unpaired t test).
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D1 Receptor Endocytosis and SignalingSurface-labeled D1 receptors moved to endocytic membrane
structures within 2 min after agonist addition and a number of
these colocalized with ACV (Figure 8A, bottom). The fraction of
D1 receptor immunoreactive structures that also contained
ACV is quantified in Figure 8B. We used the same approach to
look at the subcellular localization D1 receptors in relationship
to Gas/olf proteins. Prior to stimulation, Gas/olf immunoreactivity
localized both peripherally and in association with internal struc-
tures, whereas D1 receptors showed a peripheral distribution
consistent with plasma membrane localization (Figure 8C, top).
Following acute receptor activation, D1 receptors redistributed
to endocytic vesicles and Gas/olf immunoreactivity colocalized
with a significant fraction these structures (Figures 8C, bottom,
and 8D). Examination of this distribution at higher magnification
suggested that both downstream transduction proteins localize
to subdomains of D1 receptor-containing early endocytic
membranes (insets in Figures 8A and 8C).
DISCUSSION
To our knowledge, the present results provide the first analysis of
the relationship between D1 receptor trafficking and signaling in
neurons, and on a time scale approaching that of physiological
dopaminergic neurotransmission. Our results demonstrate
that D1 receptors enter the endocytic pathway within 1 min
after activation by either DA or synthetic agonist and that
receptor-mediated accumulation of cellular cAMP occurs with
overlapping kinetics. They also establish a causal relationship
whereby D1 receptor endocytosis augments acute dopami-
nergic signaling. We demonstrate that recycling is not required
for this response and provide evidence that the endocytosis-286 Neuron 71, 278–290, July 28, 2011 ª2011 Elsevier Inc.dependent signal is generated from an early endosomal
membrane, thus distinguishing the present results from endocy-
tosis-dependent resensitization observed for several other
GPCRs. Further, our results show that the endocytosis-depen-
dent component of the D1 receptor-mediated signal is function-
ally relevant as it is required to increase AP firing in a native brain
slice preparation.
Previous studies of D1 receptor-mediated signaling effects,
measured over longer time intervals (R30 min), have suggested
that endocytosis either inhibits (Jackson et al., 2002; Zhang
et al., 2007) or has no effect on dopaminergic signaling (Gardner
et al., 2001). Further, endocytosis has been generally shown to
attenuate cellular responsiveness, such as for AMPA receptor
endocytosis and LTD (Malenka, 2003), or restore cellular respon-
siveness, such as for resensitization of b-adrenoreceptors after
prolonged stimulation or stimulation and a refractory period
(Pippig et al., 1995). We are not aware of previous evidence
that endocytosis augments the acute cAMP response mediated
by any signaling receptor. Our study focused on cells in which
D1 receptors are primarily thought to endocytose via clathrin-
coated pits. There is evidence that caveolae mediate a slower
component of D1 receptor endocytosis in other cells, but this is
not thought to affect the acute cAMP signal (Kong et al., 2007).
As such, we believe that the presently identified role of endocy-
tosis in supporting acute D1 receptor-mediated signaling is
unique.
What is the mechanism by which rapid endocytosis contrib-
utes to dopaminergic signaling? We initially favored the hypoth-
esis that this augmentation might occur by rapid cycling of
receptors back to the plasma membrane. This was motivated
by analogy with the resensitization paradigm established for
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Figure 8. Rapid Endocytosis Promotes
Colocalization of D1 Receptors with ACV
and Gs/olf
(A) Representative confocal sections of FD1R (left,
red) and ACV (center, green) immunoreactivity
from striatal neurons incubated in the absence
(top) or 2 min after 1 mM SKF81297 application
(bottom). Scale bars represent 5 mm.
(B) Quantification of the fraction of D1R positive
puncta that colocalize with ACV prior to (black)
and after (white) 1 mM SKF81297 addition. n = 4,
3–6 cells per condition.
(C) Representative confocal optical sections of
FD1R (left, red) and Gas/olf (center, green) immu-
noreactivity from striatal neurons incubated in
the absence of agonist (top) or 2 min after 1 mM
SKF81297 application (bottom). Scale bars
represent 5 mm.
(D) Quantification of the fraction of D1R positive
puncta that colocalize with Gas/olf prior to
(black) and after (white) bath application of 1 mM
SKF81297 n = 4, 4–5 cells per condition. (*p < 0.05,
**p < 0.01, unpaired t test).
(E) Proposed model of endocytosis-dependent
augmentation of acute dopaminergic signaling.
Activation of D1 receptors stimulates ACV via
receptor coupling toGs/olf in the plasmamembrane,
creating an initial burst of cAMP produc-
tion. Activated D1 receptors are rapidly concen-
trated in clathrin-coated pits, which undergo dyna-
min-dependent endocytosis and rapid uncoating.
Additional cAMP is then generated from a nascent
endocytic membrane compartment associated
with Gs/olf and ACV. Endocytic membranes subse-
quently fuse with classical sorting endosomes that
are not signaling-competent and receptors are in-
activated by agonist dissociation in the increasingly
acidic endosomal environment. Efficient trafficking
of internalized D1 receptors back to the plasma
membrane requires the vacuolar ATPasemediating
continued endosomal acidification and EHD3
mediating membrane transfer from early to re-
cycling endosomes. Manipulations that disrupt the
function or trafficking through later sorting com-
partments (Bafilomycin, siRNAversusEHD3) do not
affect the magnitude of the acute cAMP response.
Manipulations that interfere events initiating entry of
activated D1 receptors into the endomembrane
system (HS,dynasore, siRNAversus clathrin,D360-
382) inhibit acute cAMP signaling by preventing the
second burst of cAMP production in this dynamic
trafficking cycle.
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D1 Receptor Endocytosis and Signalingseveral other GPCRs. As presently understood, however, the
resensitization paradigm explains recovery of signal responsive-
ness after prolonged or repeated activation, and does not affect
the acute signaling response (Lefkowitz, 1998; Pippig et al.,
1995). Nevertheless, given the rapid kinetics with which D1
receptors were found to traverse the recycling pathway, we
considered the hypothesis that D1 receptors might recycle so
rapidly that their resensitization might have been missed by
the previous paradigm. We rejected this hypothesis because
genetic (EHD3 knockdown) and chemical (bafilomycin A1) inhibi-
tion of the recycling pathway did not affect D1 receptor-mediatedcAMP accumulation, in contrast to the pronounced inhibition
produced by various endocytic inhibitors.
Our results thus support the alternative hypothesis that endo-
cytosis augments acute dopaminergic signaling by facilitating
direct D1 receptor-mediated signaling from amembrane domain
in the early endocytic pathway (Figure 8E). This is supported
by immunocytochemical localization data showing close prox-
imity between D1 receptors and downstream transduction
machinery upon initial entry to the endocytic pathway. While
there is no doubt that the plasma membrane is a major site of
GPCR signaling, there is emerging evidence that signaling canNeuron 71, 278–290, July 28, 2011 ª2011 Elsevier Inc. 287
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D1 Receptor Endocytosis and Signalingalso occur from the endocytic pathway, and there is presently no
compelling reason to rule out endosomal signaling via trimeric G
proteins (Calebiro et al., 2010; Sorkin and von Zastrow, 2009).
Trimeric G proteins have previously been detected on endo-
membrane compartments in mammalian cells and tissues
(Marrari et al., 2007). Further, G protein a-subunits can mediate
functionally significant signaling from endosomes in yeast
(Slessareva and Dohlman, 2006). Recent evidence suggests
that two other mammalian GPCRs (the TSH and PTH receptors)
signal via G protein-linked activation of AC directly from the
endosome membrane (Calebiro et al., 2009; Ferrandon et al.,
2009). However, the endocytosis-dependent component of
signaling described for these GPCRs is specific to a component
of the cAMP response measured tens of minutes after initial
receptor activation. Our studies establish a role of the endocytic
machinery in augmenting rapid D1 receptor-mediated signaling,
and show that D1 receptors achieve close proximity to essential
downstream signaling components upon or shortly after endo-
cytosis. It remains to be determined whether endomembrane
signaling of D1 receptors is more effective than signaling from
the plasma membrane, or if endocytosis restores signaling
activity after termination at the plasma membrane.
The present discovery has intriguing implications for neurosci-
ence. A variety of complex functions including learning and
memory, locomotion and goal-directed behaviors such as food
or drug seeking require precise regulation of dopaminergic
signaling via D1 receptors (Kelley, 2004; Sibley, 1999). Further,
recent studies in awake, behaving animals have shown transient
spikes in DA concentrations that last on the order of seconds
(Heien et al., 2005; Roitman et al., 2008; Tsai et al., 2009). Our
data indicate that robust endocytosis of D1 receptors can occur,
and is capable supporting cellular cAMP signaling on a time
scale that approaches this physiology.
In vivo measurements have shown that extracellular DA tran-
sients can vary in peak intensities from nano- to micromolar
concentration. We have demonstrated that the D1 receptor
undergoes rapid endocytosis in the upper range these concen-
trations (see Figure 1A). Interestingly, the peak concentration
measured in each of these studies varied substantially depend-
ing on the experimental paradigm that elicited DA transients.
Rewarding taste stimuli evoked DA transients in the nucleus
accumbens with peak concentrations near 50 nM (Roitman
et al., 2008), whereas electrical stimulation of dopaminergic
VTA neurons could elicit DA transients in the nucleus accumbens
with peak amplitudes >0.5 mM (Heien et al., 2005). In vivo micro-
dialysis measurements of DA in the striatum of nonhuman
primates showed dopamine concentrations >1 uM after self-
administration of cocaine (Bradberry et al., 2000). Our data
predict that low extracellular DA concentrations within the brain
would stimulate little D1 receptor endocytosis, whereas higher
extracellular DA concentrations would elicit robust D1 receptor
endocytosis and promote acute ongoing dopaminergic
signaling. Thus, endocytosis of D1 receptors may reflect amech-
anism by which signal strength, signal duration and perhaps
even the salience of a given stimulus could be effectively
encoded at the cellular level.
It is important to note that although our studies examined
D1 receptor mediated signaling with substantially improved288 Neuron 71, 278–290, July 28, 2011 ª2011 Elsevier Inc.temporal resolution relative to conventional biochemical ap-
proaches, we are not yet capable of resolving effects with the
kinetics of physiological dopamine release thought to occur
within the healthy brain. Thus our findings may be more appli-
cable to drug-induced or pathological states. Future studies,
delivering dopamine in a more transient manner and further
improving the temporal resolution of analysis, will be important
to investigate this issue.
In conclusion, the present study examined rapid D1 receptor-
mediated signaling and endocytic trafficking and identified a
role of the endocytic machinery in supporting a component of
acute dopaminergic signaling. We believe that these findings
establish a previously unanticipated relationship between the
endocytic machinery and acute cAMP signaling, and do so in
neurons that naturally respond to DA. We propose that endocy-
tosis-supported signaling by D1 receptors likely represents a
fundamental principle by which the nervous system shapes
and maintains dopaminergic responsiveness at the level of the
individual neuron.
EXPERIMENTAL PROCEDURES
cDNA Constructs and Reagents
The FLAG epitope-tagged human D1 dopamine receptor (FD1R), 360-382
deletion mutant, and Epac1-cAMPs were previously described (Nikolaev
et al., 2004; Vargas and von Zastrow, 2004; Vickery and von Zastrow, 1999).
The superecliptic pHluorin-tagged D1 dopamine receptor (SpH-D1R) was
constructed using an N-terminal cassette (Yudowski et al., 2006). For neuronal
expression all constructs were cloned into pCAGGS (Niwa et al., 1991). The
following synthetic RNA duplexes were obtained from the validated
HP GenomeWide siRNA collection (QIAGEN): Clathrin, HsCLC10; EHD3,
HsEHD3_3; nonsilencing control, AllStars Negative Control siRNA. Rhoda-
mine-labeled duplexes were used in Epac1-cAMPs FRET experiments to
verify delivery to the cells analyzed. Dynasore (Sigma) and bafilomycin A1
(Tocris Biosciences) were freshly prepared before use in DMSO. Additional
details are included in Supplemental Experimental Procedures.
Cell Culture and Transfection
Human embryonic kidney 293 (HEK293) cells were obtained from ATCC.
Striatal neurons were prepared from embryonic day 17–18 Sprague-Dawley
rats, transfected upon plating and studied 10–14 days in vitro. Details are
provided in Supplemental Experimental Procedures.
Live Imaging of SpH-D1R Localization and Trafficking
by TIRF Microscopy
TIRF microscopy was performed at 37C using a Nikon 2000E inverted micro-
scope equipped with Perfect Focus, 1003/NA1.49 TIRF objective, Nikon 488
laser TIRF illuminator and standard 488/516 excitation cube, Lambda 10-3
emission filter wheel (520/50m filter) controlled via SmartShutter (Sutter Instru-
ments) and interfaced to a PC running NIS-Elements Advanced Research
software (Nikon). More details are included in Supplemental Experimental
Procedures.
FRET Imaging
Wide field FRET imaging was carried out at 37Cusing a shutteredmercury arc
lampandstandardCFPexcitation (ET430/243andYFPemission (ET535/30m)
bandpass filters (Chroma). TIRF FRET imaging was performed using
440 nm and 514 nm laser excitation and through-the-objective evanescent
field illumination. YFP emission was collected using a 545/40 m filter, and
CFP emission was collected through a 485/30 m filter. Corrected FRET
ratios were obtained using the following equation: NFRET = [(IFRET 
BGFRET)  (ICFP  BGCFP)BTDONOR  (IYFP  BGYFP)DEACCEPTOR)]/ICFP, where
BTDONOR = donor bleed through, DEACCEPTOR = direct excitation of the
Neuron
D1 Receptor Endocytosis and Signalingacceptor, BGX = background fluorescence and IX = integrated fluorescence
intensity measured in a given channel. Additional details are provided in
Supplemental Experimental Procedures.
Immunocytochemical Methods, Fluorescence Flow Cytometry,
and Biochemical Methods
Immunocytochemical localization of receptors was carried out using M1 anti-
FLAG monoclonal antibody (Sigma). Clathrin, EEA1, ACV, and Gs/olf immuno-
localization was carried out using mouse monoclonal anti-Clathrin (x-22)
(Abcam), mouse monoclonal anti-EEA1 (BD Biosciences), rabbit anti-ACV/VI
(Santa Cruz), and mouse monoclonal GaS/olf (E-7) (Santa Cruz). Mean fluores-
cence intensity of Alexa647-labeled surface FD1Rs was collected using a flow
cytometer (Becton Dickson). Samples were maintained on ice at the end of
each experimental procedure. Ratiometric determination of agonist-induced
changes in surface FD1R and surface recovery of internalized FD1R were
performed using a modifications of previously described protocols (Haber-
stock-Debic et al., 2005; Tanowitz and von Zastrow, 2003). Immunoblot
detection of clathrin heavy chain and EHD3 were carried out using mouse
monoclonal anti-Clathrin HC (Santa Cruz) and rabbit polyclonal anti-EHD3
(Abcam) and HRP conjugated secondary antibodies. Further details are
included in Supplemental Experimental Procedures.
Electrophysiology
Acute brain slices (250–300 mm) containing the dorsal striatum were prepared
from P20–P28 male Sprague-Dawley rats. Electrophysiology was carried out
in artificial CSF, using whole-cell recording of MSNs visualized by infrared-
DIC, with 2.5 to 3.5 mm electrodes, as described in detail in Supplemental
Experimental Procedures. All animal methods were conducted in accordance
with the Guide for the Care and Use of Laboratory Animals, as adopted by the
National Institutes of Health and the Ernest Gallo Clinic and Research Center’s
Institute for Animal Care and Use Committee.SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, Supplemental Experimental
Procedures, and three movies and can be found with this article online at
doi:10.1016/j.neuron.2011.05.036.
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